QX Therapeutics, Inc
375 Morgan Ln Ste 240D
West Haven, CT 06516
Qx Therapeutics, Inc., founded in 2017, is a Delaware corporation based in West Haven, Connecticut, focused on drug research and development. The company aims to provide innovative treatments for unmet medical needs in the areas of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS).
Utilizing advanced technology, Qx Therapeutics is developing QXT101, a first-in-class treatment for ALI patients. The company has received various FDA designations and authorizations for its clinical trials, highlighting its commitment to addressing critical health challenges.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
